Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers

被引:8
作者
Chen, Lin [1 ]
Magesh, Sadagopan [1 ]
Wang, Hong [2 ]
Yang, Chung S. [2 ,5 ,6 ]
Ah-Ng Tony Kong [3 ,5 ,6 ]
Hu, Longqin [1 ,4 ,5 ,6 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Med Chem, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
[4] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan 030001, Peoples R China
[5] Canc Inst New Jersey, New Brunswick, NJ 08901 USA
[6] Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Canc Prevent Res, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
Curcumin; Iminothiazinylbutadienols; Divinylpyrimidinethiones; Anti-inflammatory agents; ARE induction; CURCUMIN ANALOGS; ANTIINFLAMMATORY PROPERTIES; NATURAL CURCUMINOIDS; HEME OXYGENASE-1; CANCER; ANTIOXIDANT; INHIBITION; STABILITY; AGENTS; ANGIOGENESIS;
D O I
10.1016/j.bmcl.2013.12.072
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Novel iminothiazinylbutadienols and divinylpyrimidinethiones were designed and synthesized as analogues of curcumin with its diketone moiety masked as a heterocyclic adduct with thiourea. The chemical stability of these novel heterocyclic compounds was improved as compared to curcumin. They exhibit longer half-lives and do not react with nucleophilic thiols under physiological conditions. In an ARE-luciferase reporter assay, some of these new curcumin analogues are more effective ARE activators than curcumin and isothiocyanates. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:940 / 943
页数:4
相关论文
共 37 条
[1]
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[2]
Synthesis and evaluation of electron-rich curcumin analogues [J].
Amolins, Michael W. ;
Peterson, Laura B. ;
Blagg, Brian S. J. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (01) :360-367
[3]
Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[4]
Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1 [J].
Awasthi, S ;
Pandya, U ;
Singhal, SS ;
Lin, JT ;
Thiviyanathan, V ;
Seifert, WE ;
Awasthi, YC ;
Ansari, GAS .
CHEMICO-BIOLOGICAL INTERACTIONS, 2000, 128 (01) :19-38
[5]
Curcurnin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element [J].
Balogun, E ;
Hoque, M ;
Gong, PF ;
Killeen, E ;
Green, CJ ;
Foresti, R ;
Alam, J ;
Motterlini, R .
BIOCHEMICAL JOURNAL, 2003, 371 :887-895
[6]
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer [J].
Bayet-Robert, Mathilde ;
Kwiatkowski, Fabrice ;
Leheurteur, Marianne ;
Gachon, Francoise ;
Planchat, Eloise ;
Abrial, Catherine ;
Mouret-Reynier, Marie-Ange ;
Durando, Xavier ;
Barthomeuf, Chantal ;
Chollet, Philippe .
CANCER BIOLOGY & THERAPY, 2010, 9 (01) :8-14
[7]
A study of the tautomerism of β-dicarbonyl compounds with special emphasis on curcuminoids [J].
Cornago, Pilar ;
Claramunt, Rosa M. ;
Bouissane, Latifa ;
Alkorta, Ibon ;
Elguero, Jose .
TETRAHEDRON, 2008, 64 (35) :8089-8094
[8]
α-glucosidase inhibition of natural curcuminoids and curcumin analogs [J].
Du, ZY ;
Liu, RR ;
Shao, WY ;
Mao, XP ;
Ma, L ;
Gu, LQ ;
Huang, ZS ;
Chan, ASC .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (02) :213-218
[9]
Chemopreventive and therapeutic effects of curcumin [J].
Duvoix, A ;
Blasius, R ;
Delhalle, S ;
Schnekenburger, M ;
Morceau, F ;
Henry, E ;
Dicato, M ;
Diederich, M .
CANCER LETTERS, 2005, 223 (02) :181-190
[10]
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration [J].
Garcea, G ;
Jones, DJL ;
Singh, R ;
Dennison, AR ;
Farmer, PB ;
Sharma, RA ;
Steward, WP ;
Gescher, AJ ;
Berry, DP .
BRITISH JOURNAL OF CANCER, 2004, 90 (05) :1011-1015